Skip to main content
Top
Published in:

Open Access 01-12-2024 | Nutrition | Research

Quality of care of oncological patients with home parenteral nutrition

Authors: Andrea Schneider, Christina Baur, Yurdagül Zopf, Helga Paula Török, Christian Sina, Christian Prinz, Heike Mönnich, Ahmed Madisch, Susen Maluck-Schölecke, Ingeborg Rötzer, Claudia Seipt, Anja Götte, Justinus Beer, Elke Jäger

Published in: Supportive Care in Cancer | Issue 12/2024

Login to get access

Abstract

Purpose

Transferring adult cancer patients from the hospital to the home environment for home parenteral nutrition (HPN) can be challenging. There is limited real-world data on how those affected perceive this situation. Our aim was to assess the quality of life (QoL) on HPN and the benefits and burdens from the cancer patient's perspective.

Methods

This observational study from Germany examined the QoL on HPN on the basis of the Functional Assessment of Cancer Therapy – G questionnaire (FACT-G). The benefits and burdens of HPN were assessed using predefined questions and answers tailored to the situation of this patient group.

Results

139 adults with advanced solid tumors in a palliative setting at 10 hospitals in Germany were eligible for the study. The follow-up was 12 weeks. At week 4, the Least-square (LS) mean (95% CI) change from baseline in the total FACT-G score was 0.9 (-2.4; 4.2) points, indicating QoL stability. HPN was associated with few complications, with a low rate of hospital readmission due to catheter-related issues (3.8%; n = 5). In the patient assessment of the benefits of HPN, the LS mean values at Week 4 ranged between 7.6 and 8.5 on a 10-point Likert scale. The most commonly perceived burden was "restricted mobility".

Conclusion

With thorough preparation for home parenteral nutrition, the transition from hospital to home care environment works well. QoL is largely maintained through HPN, and cancer patients perceive this situation as not or minimally burdensome alongside their underlying disease, although many patients found the limited mobility to be a burden.

Trial Registration number

NCT03425435 / Date of registration: February 01, 2018.
Literature
Metadata
Title
Quality of care of oncological patients with home parenteral nutrition
Authors
Andrea Schneider
Christina Baur
Yurdagül Zopf
Helga Paula Török
Christian Sina
Christian Prinz
Heike Mönnich
Ahmed Madisch
Susen Maluck-Schölecke
Ingeborg Rötzer
Claudia Seipt
Anja Götte
Justinus Beer
Elke Jäger
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-09011-2
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now